OPAY roars on prospect of entry to FTSE250

OPAY has leapt to new (adjusted) highs today, which suggests that once the company is quoted on the FTSE250 - anticipated to happen in early December - that the share price could top 400.

Further to my last blog, I've continued updating my SIPP.  This is generally in-line with the criteria I have set myself when reviewing SIPP performance earlier this year, ie:-
1) Investment companies to have a market value of greater than £500 million
2) Investment companies to have a yield of at least 3%.
3) Investment companies to be without significant debt, or able to cover debt from cash reserves (if this does not make sense that is because I am NOT a trained financial analyst).

As such I have made initial purchases in:-
Brown Group (BWNG): 190 shares @ 324
Ashmore (ASHM): 300 shares @ 263
Intermediate Capital (ICP): 275 shares @ 541
RSA Insurance (RSA): 200 shares @ 656
Unilever (ULVR): 31 shares @ 2642
BAE (BA.): 185 shares @ 438
Pearson ((PSON): 72 shares @ 1124

I have been able to finance the purchases by contributions to the SIPP and from the sale of my entire shareholding in Standard Chartered Bank (STAN) whose share price has recently collapsed with little prospect of recovery in the short-term.  As such, I've decided to cut my losses and move the capital into other companies where the prospects seem better.

Financial Data for SIPP
Target at 31^st December 2014 = £86,000

Actual Value on 31st December 2014 = £75,780 (under by £10,220)

Current Value (25^th September 2015) = £87,867 (approx), including cash of £570

Target for 31^st December 2015 = £107,160

Value at commencement of blog (1^st August 2012) = £51,684.02

Monthly contributions since commencement of blog:
36 months @ £300 = £10,800

2 months @ £750 = £1,500
Total = £12,300

Capital Growth = £87,867 less (£51,684.02 + £12,300) = £23,883 or 37%